Acadian Asset Management
ALPN

Acadian Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Acadian Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-67,156
Closed -$604K – 2082
2021
Q2 		$604K Buy
67,156
+18,615
+38% +$202K ﹤0.01% 1083
2021
Q1 		$515K Buy
48,541
+45,898
+1,737% +$572K ﹤0.01% 1182
2020
Q4 		$33K Buy
+2,643
New +$25.9K ﹤0.01% 2047
2019
Q1 		– Sell
-3,576
Closed -$13K – 2070
2018
Q4 		$13K Hold
3,576
– – ﹤0.01% 1592
2018
Q3 		$22K Buy
3,576
+1,152
+48% +$8.06K ﹤0.01% 1504
2018
Q2 		$18K Buy
+2,424
New +$20K ﹤0.01% 1537
2017
Q4 		– Sell
-2,265
Closed -$26K – 1696
2017
Q3 		$26K Hold
2,265
– – ﹤0.01% 1180
2017
Q2 		$22K Buy
2,265
+480
+27% +$4.6K ﹤0.01% 1240
2017
Q1 		$21K Buy
+1,785
New +$18.1K ﹤0.01% 1364
2016
Q4 		– Sell
-4,951
Closed -$161K – 1793
2016
Q3 		$161K Sell
4,951
-12,993
-72% -$316K ﹤0.01% 996
2016
Q2 		$330K Buy
17,944
+18
+0.1% +$320 ﹤0.01% 842
2016
Q1 		$299K Sell
17,926
-993
-5% -$19.9K ﹤0.01% 848
2015
Q4 		$587K Buy
+18,919
New +$646K ﹤0.01% 786

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management's ALPN Position: Q3 2021 in Review

Acadian Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2021, closing a stake of 67,156 shares — an estimated $604K sold.

Acadian Asset Management first reported a position in ALPN in Q4 2015 and held it in 13 quarters. The position peaked at $604K in Q2 2021. 44 funds tracked by Wall St. Rank hold ALPN as of Q3 2021.

  • Acadian Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 67,156 Alpine Immune Sciences Inc shares in Q3 2021, an estimated $604K.
  • Acadian Asset Management first reported a position in Alpine Immune Sciences Inc in Q4 2015 and held it in 13 quarters.
  • Acadian Asset Management's Alpine Immune Sciences Inc position peaked at $604K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.